Establishment and characterization of a simian virus 40-immortalized rat pancreatic stellate cell line.
Activated pancreatic stellate cells (PSCs) have recently been implicated in the pathogenesis of pancreatic fibrosis and inflammation. Primary PSCs can be subcultured only several times because of their limited growth potential. A continuous cell line would be valuable in studying molecular mechanisms of these pancreatic disorders. The aim of this study was to establish an immortalized cell line of rat PSCs. PSCs were isolated from the pancreas of male Wistar rats, and the simian virus 40 T antigen was introduced to PSCs by retrovirus-mediated gene transfer. This procedure yielded an actively growing cell line, designated as SAM-K. This cell line has been passaged repeatedly for almost 2 years, and is thus likely immortalized. SAM-K cells retained morphological characteristics of primary PSCs, and expressed alpha-smooth muscle actin, glial fibrillary acidic protein, type I collagen, fibronectin, and prolyl hydroxylases. The level of p53 expression was very high in SAM-K cells. Proliferation of SAM-K cells was stimulated by serum and platelet-derived growth factor-BB. Interleukin-1beta (IL-1beta) activated nuclear factor-kappaB, activator protein-1, and three classes of mitogen-activated protein (MAP) kinases: extracellular signal-regulated kinase1/2, c-Jun N-terminal kinase, and p38 MAP kinase. IL-1beta induced expression of intercellular adhesion molecule-1 and monocyte chemoattractant protein-1, both of which were abolished in the presence of pyrrolidine dithiocarbamate, a specific inhibitor of nuclear factor-kappaB activation. IL-1beta-induced monocyte chemoattractant protein-1 was partially inhibited by specific inhibitors of MAP kinase kinase (U0126) and of p38 MAP kinase (SB203580) whereas intercellular adhesion molecule-1 expression was not altered by the inhibitors. Thus, SAM-K would be useful for in vitro studies of cell biology and signal transduction of PSCs.
Satoh
Masahiro
M
Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai 980-8574, Japan.
Masamune
Atsushi
A
Sakai
Yoshitaka
Y
Kikuta
Kazuhiro
K
Hamada
Hirofumi
H
Shimosegawa
Tooru
T
D000818:Animals; D000952:Antigens, Polyomavirus Transforming / Q000276:immunology*; D000077214:Becaplermin; D015153:Blotting, Western; D002455:Cell Division / Q000187:drug effects; D002460:Cell Line; D018932:Chemokine CCL2 / Q000096:biosynthesis; D016895:Culture Media, Serum-Free; D003599:Cytoskeleton / Q000187:drug effects / Q000648:ultrastructure; D024202:Electrophoretic Mobility Shift Assay; D004797:Enzyme-Linked Immunosorbent Assay; D007150:Immunohistochemistry; D007375:Interleukin-1 / Q000494:pharmacology; D008297:Male; D020928:Mitogen-Activated Protein Kinases / Q000096:biosynthesis; D016328:NF-kappa B / Q000378:metabolism; D010179:Pancreas / Q000166:cytology* / Q000821:virology; D010641:Phenotype; D010982:Platelet-Derived Growth Factor / Q000494:pharmacology; D020574:Proto-Oncogene Proteins c-sis; D051381:Rats; D017208:Rats, Wistar; D018808:Transcription Factor AP-1 / Q000096:biosynthesis; D016159:Tumor Suppressor Protein p53 / Q000096:biosynthesis
D000952:Antigens, Polyomavirus Transforming; D018932:Chemokine CCL2; D016895:Culture Media, Serum-Free; D007375:Interleukin-1; D016328:NF-kappa B; D010982:Platelet-Derived Growth Factor; D020574:Proto-Oncogene Proteins c-sis; D018808:Transcription Factor AP-1; D016159:Tumor Suppressor Protein p53; D000077214:Becaplermin; D020928:Mitogen-Activated Protein Kinases